AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 178 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $13,000 | -99.9% | 295 | -99.9% | 0.00% | -100.0% |
| Q3 2018 | $18,869,000 | -9.4% | 244,675 | -1.1% | 0.04% | -11.9% |
| Q2 2018 | $20,832,000 | +3.7% | 247,324 | +0.7% | 0.04% | -2.3% |
| Q1 2018 | $20,086,000 | +38.5% | 245,613 | -3.2% | 0.04% | +43.3% |
| Q4 2017 | $14,506,000 | +2.7% | 253,726 | +19.9% | 0.03% | -3.2% |
| Q3 2017 | $14,124,000 | – | 211,598 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |